These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 28601293

  • 1. From dizziness to severe ataxia and dysarthria: New cases of anti-Ca/ARHGAP26 autoantibody-associated cerebellar ataxia suggest a broad clinical spectrum.
    Wallwitz U, Brock S, Schunck A, Wildemann B, Jarius S, Hoffmann F.
    J Neuroimmunol; 2017 Aug 15; 309():77-81. PubMed ID: 28601293
    [Abstract] [Full Text] [Related]

  • 2. Rho GTPase-activating protein 10 (ARHGAP10/GRAF2) is a novel autoantibody target in patients with autoimmune encephalitis.
    Jarius S, Komorowski L, Regula JU, Haas J, Brakopp S, Wildemann B.
    J Neurol; 2022 Oct 15; 269(10):5420-5430. PubMed ID: 35624318
    [Abstract] [Full Text] [Related]

  • 3. Two new cases of anti-Ca (anti-ARHGAP26/GRAF) autoantibody-associated cerebellar ataxia.
    Jarius S, Martínez-García P, Hernandez AL, Brase JC, Borowski K, Regula JU, Meinck HM, Stöcker W, Wildemann B, Wandinger KP.
    J Neuroinflammation; 2013 Jan 15; 10():7. PubMed ID: 23320754
    [Abstract] [Full Text] [Related]

  • 4. Anti-Ca/anti-ARHGAP26 antibodies associated with cerebellar atrophy and cognitive decline.
    Doss S, Nümann A, Ziegler A, Siebert E, Borowski K, Stöcker W, Prüss H, Wildemann B, Endres M, Jarius S.
    J Neuroimmunol; 2014 Feb 15; 267(1-2):102-4. PubMed ID: 24439423
    [Abstract] [Full Text] [Related]

  • 5. A new Purkinje cell antibody (anti-Ca) associated with subacute cerebellar ataxia: immunological characterization.
    Jarius S, Wandinger KP, Horn S, Heuer H, Wildemann B.
    J Neuroinflammation; 2010 Mar 12; 7():21. PubMed ID: 20226058
    [Abstract] [Full Text] [Related]

  • 6. Psychotic syndrome associated with anti-Ca/ARHGAP26 and voltage-gated potassium channel antibodies.
    Jarius S, Wildemann B, Stöcker W, Moser A, Wandinger KP.
    J Neuroimmunol; 2015 Sep 15; 286():79-82. PubMed ID: 26298328
    [Abstract] [Full Text] [Related]

  • 7. Rho GTPase-activating protein 17 (ARHGAP17) as additional autoimmune target in ARHGAP26-IgG/anti-Ca autoantibody-associated autoimmune encephalitis.
    Jarius S, Haas J, Wildemann B.
    J Neurol; 2023 Mar 15; 270(3):1776-1780. PubMed ID: 36333454
    [No Abstract] [Full Text] [Related]

  • 8. Anti-ARHGAP26 Autoantibodies Are Associated With Isolated Cognitive Impairment.
    Bartels F, Prüss H, Finke C.
    Front Neurol; 2018 Mar 15; 9():656. PubMed ID: 30158896
    [Abstract] [Full Text] [Related]

  • 9. 'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 2: Anti-PKC-gamma, anti-GluR-delta2, anti-Ca/ARHGAP26 and anti-VGCC.
    Jarius S, Wildemann B.
    J Neuroinflammation; 2015 Sep 17; 12():167. PubMed ID: 26377184
    [Abstract] [Full Text] [Related]

  • 10. Antibodies to the inositol 1,4,5-trisphosphate receptor type 1 (ITPR1) in cerebellar ataxia.
    Jarius S, Scharf M, Begemann N, Stöcker W, Probst C, Serysheva II, Nagel S, Graus F, Psimaras D, Wildemann B, Komorowski L.
    J Neuroinflammation; 2014 Dec 11; 11():206. PubMed ID: 25498830
    [Abstract] [Full Text] [Related]

  • 11. Untreated anti-Ca/ARHGAP26 autoantibody-associated cerebellar ataxia progressing over 27 years.
    Schegk E, Beiser I, Achtnichts L, Nedeltchev K, Bertschi M, Gschwind M.
    J Neurol; 2023 Jun 11; 270(6):3258-3260. PubMed ID: 36856845
    [No Abstract] [Full Text] [Related]

  • 12. Auto-immune cerebellar ataxia with anti-GAD antibodies accompanied by de novo late-onset type 1 diabetes mellitus.
    Bayreuther C, Hieronimus S, Ferrari P, Thomas P, Lebrun C.
    Diabetes Metab; 2008 Sep 11; 34(4 Pt 1):386-8. PubMed ID: 18583169
    [Abstract] [Full Text] [Related]

  • 13. Plasmapheresis and IVIG for Treatment of Non-Tumor Anti-Tr/DNER Antibody-Associated Ataxia: A Case Report.
    Adibi A, Rastegar-Kashkouli A, Yousefi P, Adibi I, Ahmadi E, Naghavi S.
    Cerebellum; 2024 Oct 11; 23(5):2208-2213. PubMed ID: 38874737
    [Abstract] [Full Text] [Related]

  • 14. Autoimmune Cerebellar Ataxia: Etiology and Clinical Characteristics of a Case Series from China.
    Liu M, Ren H, Zhu Y, Fan S, Bai L, Wang J, Cui L, Guan H.
    Cerebellum; 2023 Jun 11; 22(3):379-385. PubMed ID: 35618871
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [A new case of cerebellar ataxia with anti-GAD antibodies treated with corticosteroids and initially seronegative].
    Birand B, Cabre P, Bonnan M, Olindo S, Smadja D.
    Rev Med Interne; 2006 Aug 11; 27(8):616-9. PubMed ID: 16797794
    [Abstract] [Full Text] [Related]

  • 17. GTPase Regulator Associated with Focal Adhesion Kinase 1 (GRAF1) Immunoglobulin-Associated Ataxia and Neuropathy.
    Pittock SJ, Alfugham N, O'Connor K, Hinson S, Kunchok A, Lennon VA, Komorowski L, Probst C, McKeon A.
    Mov Disord Clin Pract; 2020 Nov 11; 7(8):904-909. PubMed ID: 33163561
    [Abstract] [Full Text] [Related]

  • 18. Gluten Ataxia and mGluR1 Autoimmune Encephalitis Presenting as Acute Cerebellar Ataxia: A Case Report.
    Tessendorf CD, Hueser JF, Wechsler B, Amin NN.
    S D Med; 2024 May 11; 77(5):207-210. PubMed ID: 39012773
    [Abstract] [Full Text] [Related]

  • 19. Inositol 1,4,5-trisphosphate receptor type 1 autoantibody (ITPR1-IgG/anti-Sj)-associated autoimmune cerebellar ataxia, encephalitis and peripheral neuropathy: review of the literature.
    Jarius S, Bräuninger S, Chung HY, Geis C, Haas J, Komorowski L, Wildemann B, Roth C.
    J Neuroinflammation; 2022 Jul 30; 19(1):196. PubMed ID: 35907972
    [Abstract] [Full Text] [Related]

  • 20. Intravenous immunoglobulin and rituximab for cerebellar ataxia with glutamic acid decarboxylase autoantibodies.
    Planche V, Marques A, Ulla M, Ruivard M, Durif F.
    Cerebellum; 2014 Jun 30; 13(3):318-22. PubMed ID: 24218114
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.